Skip to Main Content

Good morning, one and all. Damian Garde here, filling in for Ed Silverman in the waning hours of yet another work week. Below are your requisite tidbits to get the morning started. Hope all goes well, and do let us know if you hear anything interesting out there. …

Hydroxychloroquine did not lead to faster symptom improvement among patients who had Covid-19 symptoms and were not hospitalized, STAT reports, marking the latest study in which the repurposed malaria drug appeared useless in the current outbreak. The result is likely to inflame the long-running political conflict around the drug, which President Trump said he took to prevent Covid-19 infection. But the study itself has significant limitations that prevent it from being a final word on the subject.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!